Immutep Ltd has a consensus price target of $8.43, established from looking at the 5 latest analyst ratings. The last 3 analyst ratings were released from Baird, Baird, and Baird on August 28, 2023, August 3, 2023, and August 2, 2023. With an average price target of $7 between Baird, Baird, and Baird, there's an implied 145.61% upside for Immutep Ltd from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
08/28/2023 | IMMP | Buy Now | Immutep | $2.85 | 145.61% | Baird | Joel Beatty | → $7 | Reiterates | Outperform → Outperform | Get Alert |
08/03/2023 | IMMP | Buy Now | Immutep | $2.85 | 145.61% | Baird | Joel Beatty | → $7 | Initiates | → Outperform | Get Alert |
08/02/2023 | IMMP | Buy Now | Immutep | $2.85 | 145.61% | Baird | Joel Beatty | → $7 | Initiates | → Outperform | Get Alert |
05/18/2023 | IMMP | Buy Now | Immutep | $2.85 | 250.88% | Maxim Group | Jason McCarthy | $8 → $10 | Maintains | Buy | Get Alert |
08/03/2021 | IMMP | Buy Now | Immutep | $2.85 | 191.23% | Ladenburg Thalmann | — | — | Initiates | → Buy | Get Alert |
The latest price target for Immutep (NASDAQ: IMMP) was reported by Baird on August 28, 2023. The analyst firm set a price target for $7.00 expecting IMMP to rise to within 12 months (a possible 145.61% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for Immutep (NASDAQ: IMMP) was provided by Baird, and Immutep reiterated their outperform rating.
There is no last upgrade for Immutep.
There is no last downgrade for Immutep.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Immutep, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Immutep was filed on August 28, 2023 so you should expect the next rating to be made available sometime around August 28, 2024.
While ratings are subjective and will change, the latest Immutep (IMMP) rating was a reiterated with a price target of $0.00 to $7.00. The current price Immutep (IMMP) is trading at is $2.85, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.